Post by TP ICAP Midcap

The first half of 2026 has been another active period for the TP ICAP Midcap team, reinforcing our position as one of Europe’s leading investment banks dedicated to Small & Mid-Cap companies. Combining financing, research and investor access, we continue to support ambitious companies throughout their growth journey.   🚀 €150 million raised through Equity Capital Markets transactions   A key milestone of the semester was the successful €41 million IPO of Rising Stone, marking the first IPO completed in France in 2026. This transaction highlights our ability to support high-growth companies in accessing public markets and broadening their investor base.   Other highlighted transactions include : SEMCO TECHNOLOGIES – Secondary Offering: €50 million - Landmark secondary offering ABIONYX – Equity & Debt Financing: €33 million FERMENTALG – Capital Increase: €11 million SMAIO – Capital Increase: €3.6 million   H1 2026 highlights: • 5 ECM transactions completed • 2 listing transfers • 31 new corporate broking contracts • 8 coverage initiations • 9 investor site visits   Throughout the semester, we also expanded our research coverage and organized numerous site visits, helping investors gain deeper insights into a diverse range of companies and sectors across Europe.   We would like to thank all our clients (issuers and investors) and partners for their continued trust. With a strong pipeline of opportunities ahead, there is much more to come in H2 2026. 👏   #TPICAPMidcap #ECM #Research #CorporateAccess #IPO #SmallCaps #MidCaps #EuropeanEquities